Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Oncology
•
Endometrial Cancer
Would you offer consolidative radiation for oligometastatic uterine serous CA s/p surgery and chemotherapy with complete response?
Answer from: Radiation Oncologist at Community Practice
Usually not unless pelvis only confined disease at presentation or microscopic omental disease removed at surgery.
Comments
Radiation Oncologist at East Alabama Medical Center
Surgically pT3pN0 but on post op staging found to ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Was bone Mets bx proven?
Radiation Oncologist at East Alabama Medical Center
Unfortunately no, but PET avid and distinct lesion...
5004
5005
5008
Sign in or Register to read more
10819
Related Questions
Given the negative results of GOG-0238 but the positive results of the RUBY trial, how do you manage isolated vaginal cuff recurrence of endometrial cancer?
Would you treat with extended field pelvic radiation for a patient with FIGO IIIC1 endometrial cancer who was found with isolated tumor cells (ITCs) on a single paraaortic sentinel lymph node?
Would you offer systemic chemotherapy to a patient with at least 2023 FIGO stage IC high grade serous (p53-mut) endometrial cancer with extensive LVI for whom nodal assessment was not done?
What adjuvant treatment would you recommend for a patient with FIGO 2023 IIIB2 endometrioid endometrial adenocarcinoma (Grade 3, p53mut, MMR proficient), metastatic to the uterine serosa, bilateral ovaries, and anterior peritoneal reflection?
How would you sequence adjuvant chemo-immunotherapy (paclitaxel/carbo/pembro or paclitaxel/carbo/dostarlimab) with EBRT and vaginal cuff brachytherapy in advanced uterine cancer that meets clinical criteria for both EBRT and chemo-IO?
How would you treat a late local recurrence of extramammary Paget's disease of the vulva, not amenable to resection?
In patients treated with the KEYNOTE A-18 regimen who later recur, would you rechallenge with immunotherapy again?
Is adenocarcinoma of the vulva more radioresistant than squamous cell carcinoma?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
In patients getting concurrent chemo-immunotherapy for locally advanced cervix cancer, would you hold immunotherapy during the 2.5-3 weeks of brachytherapy?
Surgically pT3pN0 but on post op staging found to ...
Was bone Mets bx proven?
Unfortunately no, but PET avid and distinct lesion...